moderna covid-19 vaccine supply]
ANI | , Washington Dc
PUBLISHED ON JUN 03, 2021 12:03 AM IST
"Through the supply agreement, UNICEF, along with procurement partners including the PanAmerican Health Organization (PAHO), will have access to up to 34 million doses of the vaccine for around 92 countries and territories in 2021," UNICEF said.
By hindustantimes.com | Edited by Ayshee Bhaduri, Hindustan Times, New Delhi
PUBLISHED ON MAY 27, 2021 02:27 PM IST
- To counter calls by states across the country on lack of supply of vaccines, the Central government said it is “allotting enough vaccines to the states in a transparent manner as per agreed guidelines”.
PUBLISHED ON MAY 23, 2021 05:11 AM IST
- The heart problem seems to have occurred predominantly in adolescents and young adults about four days after their second dose of either the Moderna Inc or Pfizer-BioNTech vaccines, both of which are mRNA vaccines.
AFP | | Posted by Harshit Sabarwal
PUBLISHED ON MAY 12, 2021 08:47 PM IST
Moderna will deliver 10 million doses this year and by 2022 deliver 15 million booster shots that are still being tested but meant to neutralize variants of Covid-19, the company and the Australian government said in a statement.
Bloomberg | | Posted by Srivatsan K C
PUBLISHED ON MAR 07, 2021 09:38 PM IST
Gergely Gulyas, the cabinet minister to Prime Minister Viktor Orban in Hungary’s government, published the schedule in defense of a decision to opt out of additional purchases.
PUBLISHED ON JAN 31, 2021 01:53 PM IST
Doses remain scarce for now, amid a global scramble inflamed by a dispute between the European Union and British drugmaker AstraZeneca Plc.
Reuters | , Chicago
PUBLISHED ON JAN 30, 2021 07:01 PM IST
- The vaccines from Novavax Inc and Johnson & Johnson were significantly less effective at preventing Covid-19 in trial participants in South Africa, where the potent new variant is widespread, compared with countries in which this mutation is still rare.
Reuters | By Reuters| Posted by Susmita Pakrasi
PUBLISHED ON SEP 30, 2020 09:17 AM IST
New production lines at Lonza’s site in Portsmouth, New Hampshire, aim to start making vaccine ingredients in November, while three lines in Visp, deep in a valley in the Swiss Alps - to supply 300 million vaccine doses annually - should begin delivering by December.